Lung cancer affects the lungs and surrounding tissues and requires medical attention. Usually, specialists remove the lung ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Around 15,000 Kiwis living with chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in NZ, could benefit from the funding of a new medicine that will allow them to switch ...

Wheezing, a high-pitched whistling sound, is a common indicator of chronic respiratory diseases, including asthma and chronic ...

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung ...

A new strategy to treat a common form of lung cancer focuses on a protein whose loss makes it harder for the body to repair ...

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...

We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of lung cancer cases. The treatment plan and goal of treatment depend on the stage of your NSCLC ...

Living with obstructive lung disease is challenging, and managing day-to-day activities can be overwhelming. PIP can provide ...

Workers who handle coal through ports and rail say they want easier access to testing for black lung disease to align with coal miners. There is no cure for black lung disease. Gladstone-based ...